Previous close | 0.6500 |
Open | 0.6500 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 18.00 |
Expiry date | 2025-03-21 |
Day's range | 0.6500 - 0.6500 |
Contract range | N/A |
Volume | |
Open interest | 7 |
The average of price targets set by Wall Street analysts indicates a potential upside of 41.3% in Corcept (CORT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Here is how Alnylam Pharmaceuticals (ALNY) and Corcept Therapeutics (CORT) have performed compared to their sector so far this year.
ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Value Strategy” second quarter 2024 investor letter. A copy of the letter can be downloaded here. Despite strong performance from healthcare holdings, the Strategy lagged its benchmark, the Russell 2000 Value Index, due to headwinds in the materials and industrial sectors. While investors continued […]